Cell Therapy for Acute Myocardial Infarction

Rajiv Gulati, Robert D. Simari

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Evidence suggesting that bone marrow and circulating blood may harbor myocardial and vascular progenitor cells was the basis for pre-clinical studies of cell therapy for acute myocardial infarction (MI). Rapid initiation of clinical trials has since followed, with regional myocardial delivery of autologous cells being tested as adjunctive therapies for both acute and chronic left ventricular dysfunction. While clinical cell transplantation trials originally began with the explicit goal of myocardial regeneration, more recently the emphasis has shifted to attempted modulation of myocardial remodeling through other processes, such as mechanical strengthening of scar tissue and promotion of myocardial tissue survival through cellular paracrine effects. This article discusses the scientific rationale for cell therapy strategies in acute MI and provides an overview of the clinical studies that have been undertaken to date.

Original languageEnglish (US)
Pages (from-to)769-785
Number of pages17
JournalMedical Clinics of North America
Volume91
Issue number4
DOIs
StatePublished - Jul 2007

Fingerprint

Cell- and Tissue-Based Therapy
Myocardial Infarction
Tissue Survival
Cell Transplantation
Left Ventricular Dysfunction
Cicatrix
Blood Vessels
Regeneration
Stem Cells
Bone Marrow
Clinical Trials
Clinical Studies
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cell Therapy for Acute Myocardial Infarction. / Gulati, Rajiv; Simari, Robert D.

In: Medical Clinics of North America, Vol. 91, No. 4, 07.2007, p. 769-785.

Research output: Contribution to journalArticle

Gulati, Rajiv ; Simari, Robert D. / Cell Therapy for Acute Myocardial Infarction. In: Medical Clinics of North America. 2007 ; Vol. 91, No. 4. pp. 769-785.
@article{e197d8a573da4504988a36ff6c79e296,
title = "Cell Therapy for Acute Myocardial Infarction",
abstract = "Evidence suggesting that bone marrow and circulating blood may harbor myocardial and vascular progenitor cells was the basis for pre-clinical studies of cell therapy for acute myocardial infarction (MI). Rapid initiation of clinical trials has since followed, with regional myocardial delivery of autologous cells being tested as adjunctive therapies for both acute and chronic left ventricular dysfunction. While clinical cell transplantation trials originally began with the explicit goal of myocardial regeneration, more recently the emphasis has shifted to attempted modulation of myocardial remodeling through other processes, such as mechanical strengthening of scar tissue and promotion of myocardial tissue survival through cellular paracrine effects. This article discusses the scientific rationale for cell therapy strategies in acute MI and provides an overview of the clinical studies that have been undertaken to date.",
author = "Rajiv Gulati and Simari, {Robert D.}",
year = "2007",
month = "7",
doi = "10.1016/j.mcna.2007.03.003",
language = "English (US)",
volume = "91",
pages = "769--785",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Cell Therapy for Acute Myocardial Infarction

AU - Gulati, Rajiv

AU - Simari, Robert D.

PY - 2007/7

Y1 - 2007/7

N2 - Evidence suggesting that bone marrow and circulating blood may harbor myocardial and vascular progenitor cells was the basis for pre-clinical studies of cell therapy for acute myocardial infarction (MI). Rapid initiation of clinical trials has since followed, with regional myocardial delivery of autologous cells being tested as adjunctive therapies for both acute and chronic left ventricular dysfunction. While clinical cell transplantation trials originally began with the explicit goal of myocardial regeneration, more recently the emphasis has shifted to attempted modulation of myocardial remodeling through other processes, such as mechanical strengthening of scar tissue and promotion of myocardial tissue survival through cellular paracrine effects. This article discusses the scientific rationale for cell therapy strategies in acute MI and provides an overview of the clinical studies that have been undertaken to date.

AB - Evidence suggesting that bone marrow and circulating blood may harbor myocardial and vascular progenitor cells was the basis for pre-clinical studies of cell therapy for acute myocardial infarction (MI). Rapid initiation of clinical trials has since followed, with regional myocardial delivery of autologous cells being tested as adjunctive therapies for both acute and chronic left ventricular dysfunction. While clinical cell transplantation trials originally began with the explicit goal of myocardial regeneration, more recently the emphasis has shifted to attempted modulation of myocardial remodeling through other processes, such as mechanical strengthening of scar tissue and promotion of myocardial tissue survival through cellular paracrine effects. This article discusses the scientific rationale for cell therapy strategies in acute MI and provides an overview of the clinical studies that have been undertaken to date.

UR - http://www.scopus.com/inward/record.url?scp=34447303529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447303529&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2007.03.003

DO - 10.1016/j.mcna.2007.03.003

M3 - Article

C2 - 17640547

AN - SCOPUS:34447303529

VL - 91

SP - 769

EP - 785

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 4

ER -